Trius Therapeutics (Nasdaq: TSRX) has filed an amended registration statement with the SEC for an initial public offering of its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE